Atlas Private Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Atlas Private Wealth Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-65	Closed	-$12K	–	686
2021 Q3	$12K	Hold	65	–	–	0.01%	446
2021 Q2	$13K	Hold	65	–	–	0.01%	438
2021 Q1	$14K	Hold	65	–	–	0.01%	450
2020 Q4	$15K	Hold	65	–	–	0.01%	380
2020 Q3	$18K	Hold	65	–	–	0.02%	324
2020 Q2	$19K	Buy	+65	New	+$17.6K	0.02%	327

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Atlas Private Wealth Advisors's VRTX Position: Q4 2021 in Review

Atlas Private Wealth Advisors sold out of Vertex Pharmaceuticals (VRTX) in Q4 2021, closing a stake of 65 shares — an estimated $12K sold.

Atlas Private Wealth Advisors first reported a position in VRTX in Q2 2020 and held it in 6 quarters. The position peaked at $19K in Q2 2020. 1,033 funds tracked by Wall St. Rank hold VRTX as of Q4 2021.

Atlas Private Wealth Advisors reported no remaining Vertex Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Atlas Private Wealth Advisors sold 65 Vertex Pharmaceuticals shares in Q4 2021, an estimated $12K.
Atlas Private Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q2 2020 and held it in 6 quarters.
Atlas Private Wealth Advisors's Vertex Pharmaceuticals position peaked at $19K in Q2 2020.
1,033 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2021.

Based on Atlas Private Wealth Advisors's 13F filing for Q4 2021, filed 21 Apr 2022.